24 Jul 2024 • India's drug regulator, CDSCO, has approved tirzepatide, a breakthrough treatment for diabetes, marking a significant milestone for diabetes management in the country.

• Developed by a leading pharmaceutical company, this approval signals the introduction of tirzepatide as a potent therapy for type 2 diabetes, leveraging its dual benefits of lowering blood sugar levels and curbing appetite to promote weight loss—a feature not yet approved for obesity treatment in India, but is under review.

With India grappling with one of the world's highest diabetes rates and rising obesity levels, tirzepatide's approval holds promise for transforming diabetes care and addressing associated health challenges nationwide.

Source:Hindustan Times| Read full story